Emerging roles for TNIP1 in regulating post-receptor signaling

Cytokine and Growth Factor Reviews

Volumn 23, Issue 3, 2012, Pages 109-118

  Ramirez, Vincent P ^a   Gurevich, Igor ^a   Aneskievich, Brian J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

ABIN 1; Inflammation; Nuclear receptor; TNF receptor; TNIP1

Indexed keywords

CELL NUCLEUS RECEPTOR; COREPRESSOR PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN P105; REGULATOR PROTEIN; RETINOIC ACID RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3 INTERACTING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

CELL DEATH; FRAMESHIFT MUTATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; LIFE CYCLE STAGE; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPIC VARIATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATOR GENE; SHORT SURVEY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3 INTERACTING PROTEIN 1 GENE;

ANIMALS; APOPTOSIS; DNA-BINDING PROTEINS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATION; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, UNTRANSLATED; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84861712763     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2012.04.002     Document Type: Short Survey

References (85)

1. Fukushi M., Dixon J., Kimura T., Tsurutani N., Dixon M.J., Yamamoto N. Identification and cloning of a novel cellular protein Naf1 Nef-associated factor 1, that increases cell surface CD4 expression. FEBS Letters 1999, 442:83-88.
2. Gupta K., Ott D., Hope T.J., Siliciano R.F., Boeke J.D. A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions. Journal of Virology 2000, 74:11811-11824.
3. Heyninck K., De Valck D., Vanden Berghe W., Van Criekinge W., Contreras R., Fiers W., et al. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN. Journal of Cell Biology 1999, 145:1471-1482.
4. Beyaert R., Heyninck K., Van Huffel S. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. Biochemistry and Pharmacology 2000, 60:1143-1151.
5. Heyninck K., Kreike M.M., Beyaert R. Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1. FEBS Letters 2003, 536:135-140.
6. Mauro C., Pacifico F., Lavorgna A., Mellone S., Iannetti A., Acquaviva R., et al. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB. The Journal of Biological Chemistry 2006, 281:18482-18488.
7. Wagner S., Carpentier I., Rogov V., Kreike M., Ikeda F., Lohr F., et al. Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins. Oncogene 2008, 27:3739-3745.
8. Gurevich I., Aneskievich B.J. Liganded RARalpha and RARgamma interact with but are repressed by TNIP1. Biochemical and Biophysical Research Communications 2009, 389:409-414.
9. Flores A.M., Gurevich I., Zhang C., Ramirez V.P., Devens T.R., Aneskievich B.J. TNIP1 is a corepressor of agonist-bound PPARs. Archives of Biochemistry and Biophysics 2011.
10. Zhang S., Fukushi M., Hashimoto S., Gao C., Huang L., Fukuyo Y., et al. A new ERK2 binding protein Naf1, attenuates the EGF/ERK2 nuclear signaling. Biochemical and Biophysical Research Communications 2002, 297:17-23.
11. Oshima S., Turer E.E., Callahan J.A., Chai S., Advincula R., Barrera J., et al. ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature 2009, 457:906-909.
12. Gallagher J., Howlin J., McCarthy C., Murphy E.P., Bresnihan B., FitzGerald O., et al. Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarrays. FEBS Letters 2003, 551:8-12.
13. Nair R.P., Duffin K.C., Helms C., Ding J., Stuart P.E., Goldgar D., et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nature Genetics 2009, 41:199-204.
14. Han J.W., Zheng H.F., Cui Y., Sun L.D., Ye D.Q., Hu Z., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nature Genetics 2009, 41:1234-1237.
15. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1 UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nature Genetics 2009, 41:1228-1233.
16. He C.F., Liu Y.S., Cheng Y.L., Gao J.P., Pan T.M., Han J.W., et al. TNIP1, SLC15A4, ETS1 RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus 2010, 19:1181-1186.
17. Kawasaki A., Ito S., Furukawa H., Hayashi T., Goto D., Matsumoto I., et al. Association of TNFAIP3 interacting protein 1 TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study. Arthritis Research & Therapy 2010, 12:R174.
18. Allanore Y., Saad M., Dieude P., Avouac J., Distler J.H., Amouyel P., et al. Genome-wide scan identifies TNIP1 PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genetics 2011, 7:e1002091.
19. Farber E.M., Nall M.L., Watson W. Natural history of psoriasis in 61 twin pairs. Archives of Dermatology 1974, 109:207-211.
20. Deapen D., Escalante A., Weinrib L., Horwitz D., Bachman B., Roy-Burman P., et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis and Rheumatism 1992, 35:311-318.
21. Gudjonsson J.E., Elder J.T. Psoriasis: epidemiology. Clinics in Dermatology 2007, 25:535-546.
22. Rhodes B., Vyse T.J. The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology (Oxford) 2008, 47:1603-1611.
23. Perdriger A., Werner-Leyval S., Rollot-Elamrani K. The genetic basis for systemic lupus erythematosus. Joint Bone Spine 2003, 70:103-108.
24. Feghali-Bostwick C.A. Genetics and proteomics in scleroderma. Current Rheumatology reports 2005, 7:129-134.
25. Nanda S.K., Venigalla R.K., Ordureau A., Patterson-Kane J.C., Powell D.W., Toth R., et al. Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. The Journal of Experimental Medicine 2011, 208:1215-1228.
26. Gurevich I., Zhang C., Francis N., Aneskievich B.J. TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-kappaB, distributes to both nuclear and cytoplasmic locations. The Journal of Histochemistry and Cytochemistry 2011, 59:1101-1112.
27. Nestle F.O, Kaplan D.H., Barker J. Psoriasis. The New England Journal of Medicine 2009, 361:496-509.
28. Mease P.J. Psoriatic arthritis: update on pathophysiology, assessment and management. Annals of the Rheumatic Diseases 2011, 70(Suppl. 1):i77-i84.
29. Bowes J., Orozco G., Flynn E., Ho P., Brier R., Marzo-Ortega H., et al. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Annals of the Rheumatic Diseases 2011.
30. Ellinghaus E., Stuart P.E., Ellinghaus D., Nair R.P., Debrus S., Raelson J.V., et al. Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. The Journal of Investigative Dermatology 2012, 132:1133-1140.
31. Favre M., Butticaz C., Stevenson B., Jongeneel C.V., Telenti A. High frequency of alternative splicing of human genes participating in the HIV-1 life cycle: a model using TSG101, betaTrCP, PPIA INI1, NAF1, and PML. Journal of Acquired Immune Deficiency Syndromes 2003, 34:127-133.
32. Shiote Y., Ouchida M., Jitsumori Y., Ogama Y., Matsuo Y., Ishimaru F., et al. Multiple splicing variants of Naf1/ABIN-1 transcripts and their alterations in hematopoietic tumors. International Journal of Molecular Medicine 2006, 18:917-923.
33. Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2, Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nature Genetics 2010, 42:985-990.
34. Graham R.R., Cotsapas C., Davies L., Hackett R., Lessard C.J., Leon J.M., et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nature Genetics 2008, 40:1059-1061.
35. Kochi Y., Okada Y., Suzuki A., Ikari K., Terao C., Takahashi A., et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nature Genetics 2010, 42:515-519.
36. Stahl E.A., Raychaudhuri S., Remmers E.F., Xie G., Eyre S., Thomson B.P., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nature Genetics 2010, 42:508-514.
37. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:9362-9367.
38. Tung Y.C., Yeo G.S. From GWAS to biology: lessons from FTO. Annals of the New York Academy of Sciences 2011, 1220:162-171.
39. Berulava T., Horsthemke B. The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. European Journal of Human Genetics 2010.
40. Uddin M., Sturge M., Rahman P., Woods M.O. Autosome-wide copy number variation association analysis for rheumatoid arthritis using the WTCCC high-density SNP genotype data. The Journal of Rheumatology 2011, 38:797-801.
41. Dong G., Chanudet E., Zeng N., Appert A., Chen Y.W., Au W.Y., et al. A20 ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma. Clinical Cancer Research 2011, 17:1440-1451.
42. Orozco G., Eyre S., Hinks A., Bowes J., Morgan A.W., Wilson A.G., et al. Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. Annals of the Rheumatic Diseases 2011, 70:463-468.
43. Hinata K., Gervin A.M., Jennifer Zhang Y., Khavari P.A. Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin. Oncogene 2003, 22:1955-1964.
44. Halvorsen M., Martin J.S., Broadaway S., Laederach A. Disease-associated mutations that alter the RNA structural ensemble. PLoS Genetics 2010, 6:e1001074.
45. Igarashi H., Yahagi A., Saika T., Hashimoto J., Tomita T., Yoshikawa H., et al. A pro-inflammatory role for A20 and ABIN family proteins in human fibroblast-like synoviocytes in rheumatoid arthritis. Immunology Letters 2011.
46. Dinarello C.A. Anti-inflammatory agents: present and future. Cell 2010, 140:935-950.
47. Sbidian E., Maza A., Montaudie H., Gallini A., Aractingi S., Aubin F., et al. Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review. Journal of the European Academy of Dermatology and Venereology 2011, 25(Suppl. 2):28-33.
48. Michalik L., Wahli W. Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease. Biochimica et Biophysica Acta 2007, 1771:991-998.
49. Schmuth M., Jiang Y.J., Dubrac S., Elias P.M., Feingold K.R. Thematic review series: skin lipids peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. Journal of Lipid Research 2008, 49:499-509.
50. Huang W., Glass C.K. Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:1542-1549.
51. El Bakkouri K., Wullaert A., Haegman M., Heyninck K., Beyaert R. Adenoviral gene transfer of the NF-kappa B inhibitory protein ABIN-1 decreases allergic airway inflammation in a murine asthma model. The Journal of Biological Chemistry 2005, 280:17938-17944.
52. Wullaert A., Wielockx B., Van Huffel S., Bogaert V., De Geest B., Papeleu P., et al. Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality. Hepatology 2005, 42:381-389.
53. Cohen S., Ciechanover A., Kravtsova-Ivantsiv Y., Lapid D., Lahav-Baratz S. ABIN-1 negatively regulates NF-kappaB by inhibiting processing of the p105 precursor. Biochemical and Biophysical Research Communications 2009, 389:205-210.
54. Zhang S., Mahalingam M., Tsuchida N. Naf1alpha is phosphorylated in mitotic phase and required to protect cells against apoptosis. Biochemical and Biophysical Research Communications 2008, 367:364-369.
55. Schrager J.A., Der Minassian V., Marsh J.W. HIV Nef increases T cell ERK MAP kinase activity. The Journal of Biological Chemistry 2002, 277:6137-6142.
56. Herbein G., Gras G., Khan K.A., Abbas W. Macrophage signaling in HIV-1 infection. Retrovirology 2010, 7:34.
57. Hadigan C. Peroxisome proliferator-activated receptor gamma agonists and the treatment of HIV-associated lipoatrophy: unraveling the molecular mechanism of their shortcomings. The Journal of Infectious Diseases 2008, 198:1729-1731.
58. Mallon P.W., Sedwell R., Rogers G., Nolan D., Unemori P., Hoy J., et al. Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction. The Journal of Infectious Diseases 2008, 198:1794-1803.
59. Jaattela M., Mouritzen H., Elling F., Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signaling. Journal of Immunology 1996, 156:1166-1173.
60. Harhaj E.W., Dixit V.M. Deubiquitinases in the regulation of NF-kappaB signaling. Cell Research 2011, 21:22-39.
61. Iwai K., Tokunaga F. Linear polyubiquitination: a new regulator of NF-kappaB activation. EMBO Reports 2009, 10:706-713.
62. Verstrepen L., Carpentier I., Verhelst K., Beyaert R. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling. Biochemical Pharmacology 2009, 78:105-114.
63. Flores A.M., Li L., Aneskievich B.J. Isolation and functional analysis of a keratinocyte-derived, ligand-regulated nuclear receptor comodulator. The Journal of Investigative Dermatology 2004, 123:1092-1101.
64. Privalsky M.L. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annual Review of Physiology 2004, 66:315-360.
65. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
66. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annual Review of Immunology 2009, 27:693-733.
67. Guicciardi M.E., Gores G.J. Life and death by death receptors. The FASEB Journal 2009, 23:1625-1637.
68. Bouwmeester T., Bauch A., Ruffner H., Angrand P.O., Bergamini G., Croughton K., et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nature Cell Biology 2004, 6:97-105.
69. Polakowska R.R., Piacentini M., Bartlett R., Goldsmith L.A., Haake A.R. Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Developmental Dynamics 1994, 199:176-188.
70. Raj D., Brash D.E., Grossman D. Keratinocyte apoptosis in epidermal development and disease. The Journal of Investigative Dermatology 2006, 126:243-257.
71. Huang L., Verstrepen L., Heyninck K., Wullaert A., Revets H., De Baetselier P., et al. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells. Oncogene 2008, 27:6131-6140.
72. Ramos J.W. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. The International Journal of Biochemistry & Cell Biology 2008, 40:2707-2719.
73. Zheng Z.M., Specter S. Dynamic production of tumour necrosis factor-alpha (TNF-alpha) messenger RNA, intracellular and extracellular TNF-alpha by murine macrophages and possible association with protein tyrosine phosphorylation of STAT1 alpha and ERK2 as an early signal. Immunology 1996, 87:544-550.
74. Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoyiannis D., Stamatakis K., Lin J.H., et al. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 2000, 103:1071-1083.
75. Tian B., Nowak D.E., Brasier A.R. A TNF-induced gene expression program under oscillatory NF-kappaB control BMC. Genomics 2005, 6:137.
76. Tian B., Nowak D.E., Jamaluddin M., Wang S., Brasier A.R. Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling. The Journal of Biological Chemistry 2005, 280:17435-17448.
77. Fritah A., Christian M., Parker M.G. The metabolic coregulator RIP140: an update. American Journal of Physiology. Endocrinology and Metabolism 2010, 299:E335-E340.
78. Gurevich I., Flores A.M., Aneskievich B.J. Corepressors of agonist-bound nuclear receptors. Toxicology and Applied Pharmacology 2007, 223:288-298.
79. Wei L.N., Hu X., Chandra D., Seto E., Farooqui M. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. The Journal of Biological Chemistry 2000, 275:40782-40787.
80. Zhou J., Wu R., High A.A., Slaughter C.A., Finkelstein D., Rehg J.E., et al. A20-binding inhibitor of NF-kappaB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein beta activation and protects from inflammatory disease. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:E998-E1006.
81. McInturff J.E., Modlin R.L., Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. The Journal of Investigative Dermatology 2005, 125:1-8.
82. Lafyatis R., York M. Innate immunity and inflammation in systemic sclerosis. Current Opinion in Rheumatology 2009, 21:617-622.
83. Drexler S.K., Foxwell B.M. The role of toll-like receptors in chronic inflammation. The International Journal of Biochemistry & Cell Biology 2010, 42:506-518.
84. Gurevich I., Zhang C., Encarnacao P.C., Struzynski C.P., Livings S.E., Aneskievich B.J. PPARgamma and NF-kappaB regulate the gene promoter activity of their shared repressor TNIP1. Biochimica et Biophysica Acta 2011, 1819:1-15.
85. Gomariz R.P., Gutierrez-Canas I., Arranz A., Carrion M., Juarranz Y., Leceta J., et al. Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics. Current Pharmaceutical Design 2010, 16:1063-1080.